Loading
A phase 3 trial of fOLFOX (5-FU, leucovorin, oxaliplatin), FOLFOXIRI, fOLFIRI (5-FU, leucovorin, irinotecan) and cAPOX (capecitabine, oxaliplatin) in colorectal cancer, run by Dominik Paul Modest, now recruiting.
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) is a phase 3, randomised interventional study registered as NCT05008809 by Dominik Paul Modest, with a registry enrolment figure of 507 participants, started 2021-12-06 and due to reach its primary completion in 2027-11. Interventions recorded: mFOLFOX6; mFOLFOXIRI; FOLFIRI; CAPOX. Conditions listed: Colorectal Cancer. Primary outcome: Progression-free survival (PFS) time. Colorectal eligibility wording from the registry: "Histologically confirmed adenocarcinoma of the colon or rectum". Sites: Germany. No results are recorded here; the registry entry is the source.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads) and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads) and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads) and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.